ATH alterity therapeutics limited

Ann: Appendix 4E Preliminary Final Report, page-5

  1. 3,284 Posts.
    lightbulb Created with Sketch. 300
    Hi rebekah,

    Apologies, i should have wrote my post abit clearer, although i was rushing to get ready for an event.

    So please allow me to take 2.

    Yes not surprised, but it also read very doom and gloom, but going off recent results from the 202 study and the last line which I highlighted, it appears the directors are soundly confident in a good result and further progression, hence hopefully results are coming in thick and fast for a excellent end of phase 2 study read out. But we will not be spared a CR.

    Anyways, let science do its thing, and look forward to a exceptional readout read out, with institutional and MJFF stepping in with strong backing.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $100.4M
Open High Low Value Volume
1.0¢ 1.1¢ 1.0¢ $45.25K 4.114M

Buyers (Bids)

No. Vol. Price($)
31 11296464 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 7952306 5
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.